November 25, 2017 — Sitting in, or standing close to the charging port of a Tesla electric vehicle did not trigger a shock or interfere with implantable cardioverter defibrillator (ICD) performance, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions 2017.

November 25, 2017 — The majority of patients without health insurance who were hospitalized for heart attack, stroke or coronary artery bypass graft (CABG) surgery experienced catastrophic healthcare expenses before passage of the Affordable Care Act, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions.

November 25, 2017 — Heart failure associated with methamphetamine (meth) use has risen dramatically in recent years among U.S. veterans, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions.

Meth abuse is a serious problem in America, with more than 4.7 percent of the population reporting that they’ve tried the highly addictive stimulant drug at least once.

November 25, 2017 —  Treatment for gum disease, or periodontitis, significantly lowered blood pressure among Chinese patients at risk for developing high blood pressure, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions.

The Corvia intra-atrial shunt to treat diastolic heart failure.

November 25, 2017 – Results presented at the 2017 American Heart Association (AHA) Scientific Sessions and published in Circulation show that a new device designed to treat diastolic heart failure is safe and effective. The first patient in the randomized, blinded study was enrolled at The Ohio State University Ross Heart Hospital, which also enrolled the most patients in the trial.
5 Tips for Medical Device Engineers on FDA Design Controls

If you are an engineer in the medical device industry, you probably have a love/hate relationship with the FDA-mandated design controls process. While implementing design controls can feel like a major damper on your creativity and productivity in the design process, they're still a legally mandated requirement for every medical device company. 

November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk, according to an 18-year study in more than 24 000 adults published today in the European Journal of Preventive Cardiology.[1]
 
“We know that regular physical activity has major health benefits,” said first author Dr. Sangeeta Lachman, a cardiologist at the Academic Medical Centre, Amsterdam, the Netherlands.
 

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings across the nation, there appears to be very little common ground upon which stakeholders agree. Yet common aspirations that are shared by most participants include better patient care, better clinical outcomes and lower costs.

November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presented study results comparing titan nitride oxide (TiNO) coated stents (Optimax from Hexacath) versus the Synergy bioresorbable polymer coated everolimus-eluting stent (EES) from Boston Scientific, in patients with acute coronary syndrome (ACS) patients. The TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

Lumedx Corp. will present the latest in cardiovascular (CV) imaging, data management and next-generation analytics solutions at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago. The company said that they will showcase software developed to help heart and vascular hospitals improve outcomes, streamline the delivery of patient care and reduce costs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now